{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:28:34Z","timestamp":1778999314186,"version":"3.51.4"},"reference-count":44,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Environ and Mol Mutagen"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The in vivo working group (WG) considered three topics: acceptable maximum doses for negative erythrocyte micronucleus (MN) tests, validation status of MN assays in non\u2010hematopoietic tissues, and nuisance factors in the comet assay. The WG reached agreement on many issues, including: negative erythrocyte MN studies should be acceptable if dosing is conducted to Organisation for Economic Co\u2010operation and Development (OECD) test guideline (TG) 474 recommendations and if sufficient bone marrow exposure is demonstrated; consensus on the evidence required to demonstrate \u201csufficient\u201d exposure was not reached. The liver MN test using six\u2010week\u2010old rats is sufficiently validated to develop an OECD TG, but the impact of animal age warrants additional study. Ki\u201067 is a reliable marker for cellular proliferation in hepatocytes. The gastrointestinal tract MN test is useful for detecting poorly absorbed or rapidly degraded aneugens, and for genotoxic metabolites formed in the colon. Although current validation data are insufficient to support the development of an OECD TG, the methodologies are sufficient to consider as an appendix to OECD TG474. Comparison of comet assay results to laboratory historical control data (HCD) should not be used in data evaluation, unless the HCD distribution is demonstrated to be stable and the predominant source of HCD variation is due to animal, not study, factors. No universally acceptable negative control limit for any tissue was identified. Methodological differences in comet studies can result in variable data interpretations; more data are required before best practice recommendations can be made. Hedgehogs alone are unreliable indicators of cytotoxicity and additional investigations into cytotoxicity markers are required.<\/jats:p>","DOI":"10.1002\/em.22578","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T06:49:46Z","timestamp":1699512586000},"page":"81-100","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vivo genotoxicity testing strategies: Report from the 8th International Workshop on Genotoxicity Testing (\n                    <scp>IWGT<\/scp>\n                    )"],"prefix":"10.1002","volume":"66","author":[{"given":"Carol","family":"Beevers","sequence":"first","affiliation":[{"name":"Corteva Agriscience  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Uno","sequence":"additional","affiliation":[{"name":"LSI Medience Co.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Meurer","sequence":"additional","affiliation":[{"name":"BASF SE  Limburgerhof Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Hamada","sequence":"additional","affiliation":[{"name":"BoZo Research Center Inc.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Co., Ltd.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kirkland","sequence":"additional","affiliation":[{"name":"Kirkland Consulting  Tadcaster UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"LeBaron","sequence":"additional","affiliation":[{"name":"The Dow Chemical Company  Midland Michigan USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Le Curieux","sequence":"additional","affiliation":[{"name":"European Chemicals Agency  Helsinki Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3494-4109","authenticated-orcid":false,"given":"Ludovic","family":"Le Hegarat","sequence":"additional","affiliation":[{"name":"ANSES, French Agency for Food, Environmental and Occupational Health and Safety, Foug\u00e8res Laboratory, Toxicology of Contaminants Unit  Foug\u00e8res France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans\u2010Joerg","family":"Martus","sequence":"additional","affiliation":[{"name":"Preclinical Safety, Novartis Institutes for BioMedical Research  Basel Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Masumura","sequence":"additional","affiliation":[{"name":"National Institute of Health Sciences  Kawasaki Kanagawa Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakako","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Yakult Central Institute, Yakult Honsha Co., Ltd.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Charles River Labs, Genetic &amp; In Vitro Toxicology  Cook County Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Vasquez","sequence":"additional","affiliation":[{"name":"Helix3 Inc.  Morrisville North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Whitwell","sequence":"additional","affiliation":[{"name":"Labcorp Drug Development  Harrogate UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine L.","family":"Witt","sequence":"additional","affiliation":[{"name":"Division of Translational Toxicology National Institute of Environmental Health Sciences  Research Triangle Park North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2011.05.010"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2011.02.009"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2016.1214680"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00359"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22541"},{"key":"e_1_2_9_7_1","unstructured":"ECHA(2017).Guidance on information requirements and chemical safety assessment chapter R.7a: endpoint specific guidance. Version 6.0 July 2017. ECHA\u201017\u2010G\u201018\u2010EN. Available from:https:\/\/doi.org\/10.2823\/337352"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2011.2379"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2017.5113"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2021.6770"},{"key":"e_1_2_9_11_1","unstructured":"EPA. (1998)Health effects test guidelines: OPPTS 870.5395 mammalian erythrocyte micronucleus test. EPA\u2010HQ\u2010OPPT\u20102009\u20100156\u20100032."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gep048"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.21835"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2015.01.001"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-019-0128-5"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104578"},{"key":"e_1_2_9_17_1","unstructured":"ICH M3(R2). (2009)Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals international conference on harmonization of technical requirements for human use. ICH Harmonised Tripartite Guideline. Step 4."},{"key":"e_1_2_9_18_1","unstructured":"ICH S2(R1). (2011)Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use international conference on harmonization of technical requirements for human use. ICH Harmonised Tripartite Guideline. Step 4."},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105263"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.104892"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2019.03.008"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2022.503503"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2012.05.012"},{"key":"e_1_2_9_24_1","volume-title":"Test No. 474: mammalian erythrocyte micronucleus test, OECD guidelines for the testing of chemicals, section 4","author":"OECD","year":"2016"},{"key":"e_1_2_9_25_1","volume-title":"Test No. 489: in vivo mammalian alkaline comet assay test, OECD guidelines for the testing of chemicals, section 4","author":"OECD","year":"2016"},{"key":"e_1_2_9_26_1","unstructured":"OECD. (2017)Overview of the set of OECD Genetic Toxicology Test Guidelines and updates performed in 2014\u20102015 Series on Testing & Assessment No. 238\u20142nd edition. ENV\/JM\/MONO(2016)33\/REV1."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-023-00259-4"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-022-00241-6"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2019.05.008"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2014.03.002"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2013.10.002"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.21964"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2021.503386"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2010.12.005"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2010.07.006"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2023.503658"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-022-00250-5"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-021-00212-3"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/ger007"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2012.10.004"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2014.10.007"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2006.10.005"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2015.04.010"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.9b00348"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2022.503473"}],"container-title":["Environmental and Molecular Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/em.22578","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/em.22578","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/em.22578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:07:18Z","timestamp":1773464838000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/em.22578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":44,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/em.22578"],"URL":"https:\/\/doi.org\/10.1002\/em.22578","archive":["Portico"],"relation":{},"ISSN":["0893-6692","1098-2280"],"issn-type":[{"value":"0893-6692","type":"print"},{"value":"1098-2280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"2023-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}